These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 33846719)
1. Malaria Infection Is Common and Associated With Perinatal Mortality and Preterm Delivery Despite Widespread Use of Chemoprevention in Mali: An Observational Study 2010 to 2014. Mahamar A; Andemel N; Swihart B; Sidibe Y; Gaoussou S; Barry A; Traore M; Attaher O; Dembele AB; Diarra BS; Keita S; Dicko A; Duffy PE; Fried M Clin Infect Dis; 2021 Oct; 73(8):1355-1361. PubMed ID: 33846719 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi. Gutman J; Mwandama D; Wiegand RE; Ali D; Mathanga DP; Skarbinski J J Infect Dis; 2013 Sep; 208(6):907-16. PubMed ID: 23801600 [TBL] [Abstract][Full Text] [Related]
3. Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudinal study. Apinjoh TO; Ntui VN; Chi HF; Moyeh MN; Toussi CT; Mayaba JM; Tangi LN; Kwi PN; Anchang-Kimbi JK; Dionne-Odom J; Tita ATN; Achidi EA; Amambua-Ngwa A; Titanji VPK PLoS One; 2022; 17(9):e0275370. PubMed ID: 36178962 [TBL] [Abstract][Full Text] [Related]
4. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region. Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878 [TBL] [Abstract][Full Text] [Related]
5. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Verhoeff FH; Brabin BJ; Chimsuku L; Kazembe P; Russell WB; Broadhead RL Ann Trop Med Parasitol; 1998 Mar; 92(2):141-50. PubMed ID: 9625909 [TBL] [Abstract][Full Text] [Related]
6. Uptake of intermittent preventive treatment of malaria in pregnancy and risk factors for maternal anaemia and low birthweight among HIV-negative mothers in Dschang, West region of Cameroon: a cross sectional study. Kamga SLS; Ali IM; Ngangnang GR; Ulucesme MC; Keptcheu LTD; Keming EM; Tchuenkam VK; Foyet JV; Aktas M; Noubom M; Payne VK Malar J; 2024 Jan; 23(1):6. PubMed ID: 38178125 [TBL] [Abstract][Full Text] [Related]
7. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon. Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713 [TBL] [Abstract][Full Text] [Related]
8. Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso. Koita K; Bognini JD; Agboraw E; Dembélé M; Yabré S; Bihoun B; Coulibaly O; Niangaly H; N'Takpé JB; Lesosky M; Scaramuzzi D; Worrall E; Hill J; Briand V; Tinto H; Kayentao K BMC Public Health; 2024 Jan; 24(1):43. PubMed ID: 38166711 [TBL] [Abstract][Full Text] [Related]
9. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria. Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia. Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR Malar J; 2015 Feb; 14():69. PubMed ID: 25890159 [TBL] [Abstract][Full Text] [Related]
11. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania. Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania. Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022 [TBL] [Abstract][Full Text] [Related]
13. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy. Hommerich L; von Oertzen C; Bedu-Addo G; Holmberg V; Acquah PA; Eggelte TA; Bienzle U; Mockenhaupt FP Malar J; 2007 Nov; 6():144. PubMed ID: 17996048 [TBL] [Abstract][Full Text] [Related]
14. A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy. Tagbor H; Cairns M; Bojang K; Coulibaly SO; Kayentao K; Williams J; Abubakar I; Akor F; Mohammed K; Bationo R; Dabira E; Soulama A; Djimdé M; Guirou E; Awine T; Quaye S; Njie F; Ordi J; Doumbo O; Hodgson A; Oduro A; Meshnick S; Taylor S; Magnussen P; ter Kuile F; Woukeu A; Milligan P; Chandramohan D; Greenwood B PLoS One; 2015; 10(8):e0132247. PubMed ID: 26258474 [TBL] [Abstract][Full Text] [Related]
15. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight. Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009 [TBL] [Abstract][Full Text] [Related]
16. Suboptimal Intermittent Preventive Treatment in Pregnancy (IPTp) is Associated With an Increased Risk of Submicroscopic Plasmodium falciparum Infection in Pregnant Women: A Prospective Cohort Study in Benin. Hounkonnou CPA; Ndam NT; Fievet N; Accrombessi M; Yovo E; Mama A; Sossou D; Vianou B; Massougbodji A; Briand V; Cot M; Cottrell G Clin Infect Dis; 2021 Dec; 73(11):e3759-e3767. PubMed ID: 32901806 [TBL] [Abstract][Full Text] [Related]
17. Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. Diakite OS; Kayentao K; Traoré BT; Djimde A; Traoré B; Diallo M; Ongoiba A; Doumtabé D; Doumbo S; Traoré MS; Dara A; Guindo O; Karim DM; Coulibaly S; Bougoudogo F; Ter Kuile FO; Danis M; Doumbo OK Clin Infect Dis; 2011 Aug; 53(3):215-23. PubMed ID: 21765069 [TBL] [Abstract][Full Text] [Related]
18. Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial. Madanitsa M; Kalilani L; Mwapasa V; van Eijk AM; Khairallah C; Ali D; Pace C; Smedley J; Thwai KL; Levitt B; Wang D; Kang'ombe A; Faragher B; Taylor SM; Meshnick S; Ter Kuile FO PLoS Med; 2016 Sep; 13(9):e1002124. PubMed ID: 27622558 [TBL] [Abstract][Full Text] [Related]
19. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model. Walker PG; Floyd J; Ter Kuile F; Cairns M PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259 [TBL] [Abstract][Full Text] [Related]
20. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial. Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]